Skip to main content
. 2019 Jun 27;3(1):e000456. doi: 10.1136/bmjpo-2019-000456

Figure 2.

Figure 2

Immunisation rates.13 Slovenia PCV rate (50%) not included in the graphic. PCV immunisation rate not available for Austria and Spain. DTaP: percentage of surviving infants who received the third dose of diphtheria and tetanus toxoid with pertussis-containing vaccine. MCV: percentage of surviving infants who received the first dose of measles-containing vaccine. In countries where the national schedule recommends the first dose of MCV at 12 months or later based on the epidemiology of disease in the country, coverage estimates reflect the percentage of children who received the first dose of MCV as recommended. Hib: percentage of surviving infants who received the third dose of Hib-containing vaccine. PCV: percentage of surviving infants who received the third dose of PCV. In countries where the national schedule recommends two doses during infancy and a booster dose at 12 months or later based on the epidemiology of disease in the country, coverage estimates may reflect the percentage of surviving infants who received two doses of PCV prior to the first birthday. DTaP, diphtheria, tetanus and acellular pertussis vaccine; Hib, Haemophilus influenzae type b vaccine; PCV, pneumococcal conjugate vaccine. MCV, measles-containing vaccine.